Overview Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis Status: Completed Trial end date: 2016-03-01 Target enrollment: Participant gender: Summary The primary purpose of this study is to assess the efficacy and safety of treatment with Kiacta in adult patients with AA Amyloidosis. Phase: Phase 3 Details Lead Sponsor: C.T. Development America, Inc.